The DOI matches its Crossref record.
Risk of Malignancy in Serous Cystic Neoplasms of the Pancreas
Abstract
Background: In contrast to mucinous cystic neoplasms of the pancreas, which are known to have considerable malignant potential, the serous variant is generally thought to be benign. There are, however, several reports of malignancy in serous cystic neoplasms of the pancreas. Aims: To assess the risk of malignancy of serous cystic tumors of the pancreas and to investigate specific clinical and histological features. Methods: Clinical and pathological characteristics of benign and malignant serous cystic neoplasms of the pancreas were investigated by a review of the literature and documented by a case of a serous cystadenocarcinoma and immunohistochemical analysis of a series of serous cystadenomas. Reviewing the literature prevalence, age and sex distribution of serous cystic neoplasms were analyzed. Results: The prevalence of cancer among serous cystic neoplasms reported since 1989 was 3%. Serous cystadenoma of the pancreas present at an earlier age (61 years) than serous cystadenocarcinoma (66 years; p = 0.056) and are symptomatic in the majority of patients.Pathological examination of the primary tumor was not able to distinguish cystadenoma from cystadenocarcinoma in 38% of cases. In 25% the diagnosis of cancer was established only after growth of metachronous metastases. In the present case, nuclear atypia, papillary structures, proliferation marker Ki-67 and p53 protein were increased in the primary tumor and/or metachronous metastasis. Conclusion: Serous cystic neoplasms of the pancreas do have malignant potential with a risk of malignancy of 3% and should be surgically treated if the operative risk is acceptable. Routine analysis of genetic and proliferation markers may improve diagnosis of malignancy in these tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
European evidence-based guidelines on pancreatic cystic neoplasms
The European Study Group on Cystic Tumours of the Pancreas (2018) · Gut · doi:10.1136/gutjnl-2018-316027 · Cited by 1,417
European experts consensus statement on cystic tumours of the pancreas
Del Chiaro, M., Verbeke, C., Salvia, R., Klöppel, G., Werner, J., McKay, C., Friess, H., Manfredi, R., Van Cutsem, E., Löhr, M., et al. (2013) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.01.010 · Cited by 498
Self-citationSerous Cystadenoma of the Pancreas: Tumor Growth Rates and Recommendations for Treatment
Tseng, J. F., Warshaw, A. L., Sahani, D. V., Lauwers, G. Y., Rattner, D. W., & Castillo, C. F.-D. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000179651.21193.2c · Cited by 400
Jais, B., Rebours, V, Malleo, G., Salvia, R., Fontana, M., Maggino, L., Bassi, C., Manfredi, R., Moran, R., Lennon, A. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309638 · Cited by 372
Thornton, G. D., McPhail, M. J. W., Nayagam, S., Hewitt, M. J., Vlavianos, P., & Monahan, K. J. (2013) · Pancreatology · doi:10.1016/j.pan.2012.11.313 · Cited by 289
Metadata
- Authors
- Strobel, O., Z’graggen, K., Schmitz-Winnenthal, F. H., Friess, H., Kappeler, A., Zimmermann, A., Uhl, W., & Büchler, M. W.
- Venue
- Digestion
- Publisher
- S. Karger AG
- Published
- 2003
- Volume
- 68
- Issue
- 1
- Pages
- 24-33
- ISSN
- 0012-2823 (ISSN-L)
- 1421-9867
- OpenAlex
- W2082254835
- Cited by
- 184
- References
- 0
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk of Malignancy in Serous Cystic Neoplasms of the Pancreas. https://app.cochat.ai/papers/10.1159/000073222
- The paper
- Strobel, O., Z’graggen, K., Schmitz-Winnenthal, F. H., Friess, H., Kappeler, A., Zimmermann, A., Uhl, W., & Büchler, M. W. (2003). Risk of Malignancy in Serous Cystic Neoplasms of the Pancreas. Digestion. https://doi.org/10.1159/000073222
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.